Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis after conservative surgery

Telimaa S, S Telimaa, Sakari Telimaa, Rönnberg L, Antti Kauppila, L Rönnberg, A Kauppila, Kauppila A
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 1987 · vol. 1(4) , pp. 363–371 · doi:10.3109/09513598709082709 · PMID:2972171 · W2038644561
RCT OA: closed CC0 ⤵ 108 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

Postoperative treatment of advanced endometriosis with danazol or high-dose medroxyprogesterone acetate, compared to placebo, significantly reduced pelvic pain and peritoneal lesion size.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

To evaluate the clinical value of postoperative hormone therapy in endometriosis, 60 patients with advanced disease were randomized to receive in a double-blind study danazol (200 mg, 3 times daily), medroxyprogesterone acetate (MPA) (100 mg daily) or placebo post-operatively for 6 months. Treatment efficacy was evaluated clinically and at laparoscopy 6 months after medication. In relation to placebo, danazol and high-dose MPA treatments, which did not differ from each other in efficacy, significantly alleviated pelvic pain. In addition, the peritoneal endometriosis lesions found at 6-months laparoscopy were significantly smaller in the MPA and danazol groups than in the placebo group. Breakthrough bleeding, weight gain and acne complicated danazol treatment but only breakthrough bleeding complicated MPA treatment. These data suggest that postoperative treatment of advanced endometriosis with high-dose MPA or danazol is clinically beneficial.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Danazol Endometriosis Medroxyprogesterone Pregnadienes Analysis of Variance Analysis of Variance Danazol Danazol Double-Blind Method Double-Blind Method Endometriosis Endometriosis Endometriosis Female Female Humans Humans Medroxyprogesterone Medroxyprogesterone Medroxyprogesterone

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (37)

Cited by (50)

Source provenance

europepmc
last seen: 2026-10-29T06:15:59.360273+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:21:58.428726+00:00
unpaywall
last seen: 2026-10-29T06:31:18.914191+00:00
License: CC0 · commercial use OK